Angiodynamics (ANGO) EBITDA Margin (2010 - 2026)
Angiodynamics' (ANGO) quarterly EBITDA Margin came in at 11.77% in Q2 2026, down 455.0% on a YoY basis from 3.32% in Q2 2025, and up 28.72% quarter-over-quarter from 16.51% in Q1 2026.
Powered by 
Analysis
Angiodynamics (ANGO) EBITDA Margin (2010 - 2026) Analysis & Trends
Angiodynamics (ANGO) has reported EBITDA Margin for 17 consecutive years, with 11.77% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBITDA Margin fell 455.0% year-over-year to 11.77%; the trailing twelve-month figure through May 2026 stood at 12.47% (up 119.0% YoY), and the FY2026 full-year result was 12.47%, up 119.0% from the prior year.
- EBITDA Margin improved to 11.77% in Q2 2026 per ANGO's latest filing, from 16.51% in the prior quarter.
- Across five years, EBITDA Margin topped out at 44.52% in Q3 2023 and bottomed at 265.88% in Q1 2024.
- Historically, EBITDA Margin has averaged 24.35% across 5 years, with a median of 13.96% in 2025.
- The sharpest annual moves came in 2024 and 2025: EBITDA Margin plunged 25482 bps in 2024, then surged 25203 bps in 2025.
- Over 5 years, EBITDA Margin stood at 9.5% in 2022, then slumped by 75 bps to 16.59% in 2023, then gained by 8 bps to 15.23% in 2024, then jumped by 49 bps to 7.71% in 2025, then sank by 53 bps to 11.77% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 11.77%, 16.51%, and 7.71% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 19.15% |
| 10 | Angiodynamics | 633.27 Mn | 579.41 Mn | 46.77 Mn | -11.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -11.77% |
| Feb 28, 2026 | -16.51% |
| Nov 30, 2025 | -7.71% |
| Aug 31, 2025 | -14.07% |
| May 31, 2025 | -7.22% |
| Feb 28, 2025 | -13.85% |
| Nov 30, 2024 | -15.23% |
| Aug 31, 2024 | -19.41% |
| May 31, 2024 | -20.36% |
| Feb 29, 2024 | -265.88% |
| Nov 30, 2023 | -16.59% |
| Aug 31, 2023 | 44.52% |
| May 31, 2023 | -22.88% |
| Feb 28, 2023 | -11.06% |
| Nov 30, 2022 | -9.50% |
| Aug 31, 2022 | -16.31% |
| May 31, 2022 | -7.35% |
| Feb 28, 2022 | -7.16% |
| Nov 30, 2021 | -11.09% |
| Aug 31, 2021 | -10.52% |